Watch this series of clinical cases- would you have made the same treatment choices to manage these complications?

- Unusual complication during an angiogram
- When wires give you troube
- Routine PCI complications: a CTO technique to the rescue
- Entrapment and fracture of coronary guidewire
- An unexpected Impella...

After a retrospective of the best images of the GulfPCR-GIM 2021 Congress, attend the presentation of the best clinical case award to the 2021 winner and listen to the closing highlights that put an end to this edition.

In this session whose aim is to highlight imaging value, watch the case of a 64-year-old man with diabetes, hypertension and severe interstitial lung disease who presented with new onset of shortness of breath and functional class NYHA II-III for 3 days...

A 70-year-old male patient was referred to hospital with signs of acute myocardial infarction. Echocardiography confirmed impaired left ventricular function and severe low flow, low gradient aortic valve stenosis. Would you go for surgical aortic valve replacement or transfemoral TAVI?

Watch this session to get proved that provisional side-branch stenting is recommended for the majority of bifurcation lesions, including the LM, that DK-Crush appears to be the best two-stent technique for important SB with complex stenoses, and that imaging and physiology can optimize stenting strategy decision...

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2022 Scientific Sessions #ACC22.

Elad Asher provides his take on this phase IIb trial in healthy people ages 50 to 80 showing that the novel intravenous treatment bentracimab significantly restored platelet function in patients receiving oral P2Y12 inhibitor ticagrelor. The clinical trial was presented by Deepak L. Bhatt at the American College of Cardiology...

In this interview, Mirvat Alasnag asks Shamir R. Mehta about the results of a prespecified analysis of the COMPLETE study which he presented during the ACC 2022 Scientific sessions. 

Luis Ortega-Paz interviews Frederik Zimmermann, first co-author of the FAME 3 Trial which he presented during the American College of Cardiology’s annual scientific sessions. The trial was published simultaneously in the journal Circulation.

This case-based and practical guidance session will enable you to know how to tailor the available technology for lesions with high calcium content, understand the limitations of each device used for plaque modification, and overcome difficulties with each modality.

Dejan Milasinovic provides his take on the EDIT-CMD Randomized Clinical Trial which aimed to assess the efficacy of diltiazem to improve coronary vasomotor dysfunction in angina and nonobstructive coronary arteries.

Nicola Ryan provides a PICOT analysis of PACMAN AMI: a double-blind, placebo-controlled, randomized trial presented at ACC 2022 and simultaneously published in JAMA.

Let's consider the modes of late stent failure in this session that will also enable you to understand the role of intravascular imaging in guiding evaluation of stent failure, and to enhance your skillset in treating late stent failure.

Michele Pighi provides his take on the National Cardiovascular LAAO Registry that analyzed data from 51,333 patients who underwent LAAO procedures with the WATCHMAN device between 2016-2019, as part of the College's NCDR registries.

Alessandro Sticchi and Luigi Biasco provide their take on the 1-year results of the CLASP TR study which were presented by Dr Adan Greenbaum, co-director of the Emory Structural Heart and Valve Center (Atlanta, GA) during the 2022 American College of Cardiology annual Congress held in Washington D.C.

Watch the LIVE case of a 76-year-old female patient with DM and HTN, who had MPI 2 years ago and who presented with severe aortic stenosis, and discuss device selection based on coronary anatomy, cerebral protection device use, and peripheral vascular access management.

Pierre Deharo and Giuseppe Di Gioia provide their take on this analysis of the 5 years incidence, outcomes and predictors of hemodynamic SVD in patients undergoing TAVI and surgery from the Corevalve US Pivotal and SURTAVI trials.

Francesco Costa analyses the results of ADAPT-TAVR, a prospective randomized trial on edoxaban vs dual antiplatelet therapy for valve thrombosis and cerebral thromboembolism after transcatheter aortic-valve replacement.

Mirvat Alasnag interviews Cesar Herrera, Hadley Wilson & Benny Levenson, principal investigators of the GHATI trial: A two-year report of 4,015 patients enrolled in the American College of Cardiology - Global Heart Attack Treatment Initiative.